The firm took a Q4 $1.38 billion impairment charge and will take $327 million in restructuring costs this year in the face of “intensifying competition.”
The firm took a Q4 $1.38 billion impairment charge and will take $327 million in restructuring costs this year in the face of “intensifying competition.”